Cost-utility analysis of maintenance therapy with gemcitabine or erlotinib vs observation with predefined second-line treatment after cisplatin-gemcitabine induction chemotherapy for advanced NSCLC: IFCT-GFPC 0502-Eco phase III study.

Borget, Isabelle; Pérol, Maurice; Pérol, David; Lavolé, Armelle; Greillier, Laurent; Dô, Pascal; Westeel, Virginie; Crequit, Jacky; Léna, Hervé; Monnet, Isabelle; Le Caer, Hervé; Fournel, Pierre; Falchero, Lionel; Poudenx, Michel; Vaylet, Fabien; Chabaud, Sylvie; Vergnenegre, Alain; Zalcman, Gérard; Chouaïd, Christos

Borget, Isabelle; Pérol, Maurice; Pérol, David; Lavolé, Armelle; Greillier, Laurent; Dô, Pascal; Westeel, Virginie; Crequit, Jacky; Léna, Hervé; Monnet, Isabelle; Le Caer, Hervé; Fournel, Pierre; Falchero, Lionel; Poudenx, Michel; Vaylet, Fabien; Chabaud, Sylvie; Vergnenegre, Alain; Zalcman, Gérard; Chouaïd, Christos.

Affiliation

Borget I; Études et Recherche en Économie de la Santé, Service de Biostatistique et d'Epidémiologie, Institut Gustave Roussy, 114, rue Edouard-Vaillant, 94805 Villejuif, Cedex, France. isabelle.borget@igr.fr.

BMC Cancer ; 14: 953, 2014 Dec 15.

Article in En | MEDLINE | ID: mdl-25511923

Subject(s)

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Induction Chemotherapy / Maintenance Chemotherapy / Lung Neoplasms / Antineoplastic Agents Type of study: Clinical_trials / Health_economic_evaluation / Observational_studies Aspects: Patient_preference Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: BMC Cancer Journal subject: NEOPLASIAS Year: 2014 Document type: Article Affiliation country: Francia Country of publication: Reino Unido

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google